Hoy J - Search Results

1

Mycoplasma pneumoniae infection associated with an acute brainstem syndrome.

Pellegrini M, O'Brien TJ, Hoy J, Sedal L. Pellegrini M, et al. Among authors: hoy j. Acta Neurol Scand. 1996 Feb-Mar;93(2-3):203-6. doi: 10.1111/j.1600-0404.1996.tb00200.x. Acta Neurol Scand. 1996. PMID: 8741144 Review.

2

Long-term foscarnet therapy not associated with the development of foscarnet-resistant human immunodeficiency virus type 1 in an acquired immunodeficiency syndrome patient.

Tachedjian G, Hoy J, McGavin K, Birch C. Tachedjian G, et al. Among authors: hoy j. J Med Virol. 1994 Feb;42(2):207-11. doi: 10.1002/jmv.1890420220. J Med Virol. 1994. PMID: 7512615

3

Management of CMV infections in HIV-infected patients.

Hoy J. Hoy J. Adv Exp Med Biol. 1999;458:77-87. doi: 10.1007/978-1-4615-4743-3_8. Adv Exp Med Biol. 1999. PMID: 10549381 Review. No abstract available.

4

Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing.

Birch C, Middleton T, Hales G, Cooper D, Law M, Crowe S, Hoy J, Emery S. Birch C, et al. Among authors: hoy j. J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):57-61. doi: 10.1097/00126334-200301010-00008. J Acquir Immune Defic Syndr. 2003. PMID: 12514414

5

An HIV-1 integrase genotype assay for the detection of drug resistance mutations.

Hearps AC, Greengrass V, Hoy J, Crowe SM. Hearps AC, et al. Among authors: hoy j. Sex Health. 2009 Dec;6(4):305-9. doi: 10.1071/SH09041. Sex Health. 2009. PMID: 19917199

6

Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.

Rajasuriar R, Booth D, Solomon A, Chua K, Spelman T, Gouillou M, Schlub TE, Davenport M, Crowe S, Elliott J, Hoy J, Fairley C, Stewart G, Cameron P, Lewin SR. Rajasuriar R, et al. Among authors: hoy j. J Infect Dis. 2010 Oct 15;202(8):1254-64. doi: 10.1086/656369. J Infect Dis. 2010. PMID: 20812848

7

Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection.

Lichtfuss GF, Hoy J, Rajasuriar R, Kramski M, Crowe SM, Lewin SR. Lichtfuss GF, et al. Among authors: hoy j. Biomark Med. 2011 Apr;5(2):171-86. doi: 10.2217/bmm.11.15. Biomark Med. 2011. PMID: 21473720 Review.

8

Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.

Rajasuriar R, Gouillou M, Spelman T, Read T, Hoy J, Law M, Cameron PU, Petoumenos K, Lewin SR. Rajasuriar R, et al. Among authors: hoy j. PLoS One. 2011;6(6):e20713. doi: 10.1371/journal.pone.0020713. Epub 2011 Jun 2. PLoS One. 2011. PMID: 21674057 Free PMC article.

9

Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.

Smith DE, Carr A, Law M, Martin A, Hudson J, Hoy J, Cooper DA. Smith DE, et al. Among authors: hoy j. AIDS. 2002 Dec 6;16(18):2489-91. doi: 10.1097/00002030-200212060-00020. AIDS. 2002. PMID: 12461429 Clinical Trial. No abstract available.

10

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

Martin A, Smith DE, Carr A, Ringland C, Amin J, Emery S, Hoy J, Workman C, Doong N, Freund J, Cooper DA; Mitochondrial Toxicity Study Group. Martin A, et al. Among authors: hoy j. AIDS. 2004 Apr 30;18(7):1029-36. doi: 10.1097/00002030-200404300-00011. AIDS. 2004. PMID: 15096806 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

484 results

Search Page

Filters